![Ariva](https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/907/normal/Screen_Shot_2016-01-27_at_14.41.07.png?1453905685)
Innovent Delivers Oral Presentation on Clinical Data of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Advanced Non-small Cell Lung Cancer and Other Solid Tumors at the 2024 ESMO Virtual Plenary
Ariva,
PR Newswire SAN FRANCISCO and SUZHOU, China, June 13, 2024 SAN FRANCISCO and SUZHOU, China, June 13, 2024 /PRNewswire/ -…